AUS
NZ
UK
CA
USA
IND
Healthcare
CSL’s Canadian HEMGENIX Milestone Could Shift Market Attention Toward Gene Therapy Growth
May 21, 2026 11:18 AM AEST| By SamCSL’s Canadian reimbursement milestone has renewed attention on the company’s gene therapy growth strategy and commercial execution.
Why This ASX Healthcare Stock Is Gaining Fresh Attention
May 21, 2026 10:56 AM AEST| By SamAFT Pharmaceuticals strengthened investor attention after reporting stronger earnings growth and ongoing international healthcare expansion.
AFT Pharma ASX 300 Records Strong FY Twenty Six Profit
May 21, 2026 09:59 AM AEST| By SamAFT Pharmaceuticals recorded a landmark FY twenty six financial outcome with wider international operations, stronger medicine distribution, and expanding healthcare market activity.
Why Is CSL Staying in Focus Across the ASX 200 Market?
May 21, 2026 09:52 AM AEST| By SamCSL remained closely watched across the healthcare sector as biotechnology and pharmaceutical companies continued attracting attention within the ASX market.
Could All Ordinaries TGA Approval Lift OncoSil Focus?
May 20, 2026 06:36 PM AEST| By SamOncoSil strengthened healthcare sector visibility after securing TGA approval for its oncology treatment device as biotechnology innovation and medical technology activity remained central industry themes.
Why These ASX Penny Stocks Are Drawing Fresh Attention
May 20, 2026 04:23 PM AEST| By SamAudinate Group, Alcidion Group, and Austin Engineering are gaining attention as Australian investors focus on financially stable smaller companies operating across technology, healthcare, and mining-linked sectors amid cautious market conditions.
Cracks Beneath the ASX 200 Calm Are Getting Hard to Ignore
May 20, 2026 04:02 PM AEST| By SamAustralian shares may appear stable on the surface, but weakness across retail, healthcare, banking and technology stocks reveals growing pressure from inflation, oil prices and slowing consumer demand.
Could ASX 300 Oncology Progress Lift Nyrada Focus?
May 20, 2026 03:15 PM AEST| By SamNyrada advanced oncology-focused Xolatryp research and US patent activity as biotechnology innovation and pharmaceutical intellectual property discussions strengthened across the healthcare sector.
Biotech Buzz Builds as ASX Drug Developers Chase Breakthroughs
May 20, 2026 02:35 PM AEST| By SamAustralian biotech companies are regaining market attention after new clinical trial developments involving cancer and neurological treatment programs boosted sentiment across healthcare-focused ASX small caps.
ASX 200 Health Tech Share Rebounds As Pro Medicus Returns To Market Spotlight
May 20, 2026 09:31 AM AEST| By SamPro Medicus returned to market focus as enterprise imaging demand, US healthcare exposure, and broader digital healthcare trends continued supporting attention toward ASX health-tech shares.
Why Pro Medicus Shares Are Drawing Market Attention
May 19, 2026 06:36 PM AEST| By SamExplore how Pro Medicus is strengthening its position in healthcare imaging technology through innovation, financial resilience, and growing global demand within the Australian share market.
Nyrada Strengthens Innovation Push With Xolatryp Patent Progress
May 19, 2026 06:23 PM AEST| By SamNyrada strengthens its biotechnology portfolio after securing a key US patent milestone for Xolatryp, supporting long-term innovation in cardiac therapy research and expanding industry attention.
Island Pharmaceuticals Builds Momentum in Antiviral Space
May 19, 2026 05:26 PM AEST| By SamIsland Pharmaceuticals continues strengthening its antiviral development strategy while maintaining financial flexibility, placing the biotechnology company in focus among healthcare market watchers.
BCAL Diagnostics Broadens Early Detection Reach Across Australia
May 19, 2026 04:18 PM AEST| By SamBCAL Diagnostics is advancing early cancer detection access through national GP integration, telehealth support, and expanded healthcare infrastructure across Australia and global markets.
Pro Medicus Strengthens US Expansion With New Imaging Agreement
May 19, 2026 04:06 PM AEST| By SamPro Medicus strengthens its US healthcare footprint with a major cloud imaging agreement, highlighting growing demand for advanced medical technology solutions across global healthcare networks.
Oil Shock and Banking Drag Sink Australian Shares
May 19, 2026 03:36 PM AEST| By SamAustralian shares weakened as rising oil prices, geopolitical tensions, and heavy selling in banking and healthcare stocks triggered cautious sentiment across multiple sectors.
Market Rebound Sparks Fresh Confidence Across Australian Shares
May 19, 2026 03:28 PM AEST| By SamAustralian shares rebounded after recent market weakness as retail, healthcare, insurance, and industrial stocks regained momentum, while mining companies remained under pressure amid softer oil prices and easing geopolitical concerns.
Why These Australian Shares Are Back in the Spotlight
May 19, 2026 03:08 PM AEST| By SamAustralian healthcare, gold and consumer-focused shares are regaining momentum as market sentiment improves and investors reassess long-term growth sectors across the local equities landscape.
Why These Beaten-Down ASX Shares Are Turning Heads
May 19, 2026 02:54 PM AEST| By SamSeveral heavily sold-down Australian shares rebounded as market sentiment improved, though ongoing economic pressure, regulation, and global uncertainty continue shaping the recovery outlook across healthcare, retail, industrial, and wagering sectors...
Lithium Stock Roars Back as Woolworths Leads Market Charge
May 19, 2026 02:19 PM AEST| By SamAustralian shares advanced as supermarket stocks gained favour and lithium optimism returned after Mineral Resources restarted a major mine, while gold, healthcare and technology sectors delivered mixed market reactions.
Advertise your brand on Kalkine Media